Industry News
Australia and China to build new nanotechnology lab
The governments of Australia and China have announced that they will jointly fund a new state-of-the-art nanotechnology laboratory in China. [ + ]
Applications open for 14th round of CRCs
Federal innovation Minister Senator Kim Carr today announced the opening of round 14 of the CRC ( cooperative research centres) program, inviting companies around Australia to partner up and submit their applications for funding. [ + ]
Opinion: Private funding – enabling Australian biomedical research
The biomedical sphere is one of the toughest areas in which to gain funding – the level of competition, coupled with limited public funding makes it difficult to take many areas of research forward. With so many subjects worthy of development, private philanthropy is a significant enabler of vital research projects across Australia. [ + ]
Centre targets epidemic battles
The early identification of biomarkers to aid in the fight against diabetes, depression and other epidemic diseases will be the focus of a new Australian-German centre launched at The Australian National University.
[ + ]Australia’s first iPS Type 1 diabetes cells created
Researchers at Monash University's Institute of Medical Research have used iPS (induced pluripotent stem cells) technology to become the first in Australia to create Type 1 diabetes cells in a laboratory. [ + ]
Researchers find a 'liberal gene'
Liberals may owe their political outlook partly to their genetic make-up, according to new research from the University of California, San Diego, and Harvard University.
[ + ]Global partners get their teeth into stem cell research
Stem cell research will be a focus of Australia’s first international translational dental science research program, based at The University of Western Australia.
[ + ]Novotech kicks off Phase Ib trials in Australia and NZ for OncoMed
California-based biopharma company, OncoMed Pharmaceuticals, has announced it will run three Phase Ib clinical trials in Australia and New Zealand testing its humanised monoclonal antibody therapies for cancer via local CRO, Novotech. [ + ]
Holista signs ‘halal’ deals in Malaysia
Listed Australian biotech Holista CollTech announced today that it has signed two significant deals regarding the research and commercialisation of its halal food-grade sheep collagen. [ + ]
Leading antiemetic Aloxi receives PBS approval
The popular Swiss-made antiemetic post-chemo drug Aloxi (palonosetron hydrochloride) has been approved for reimbursement under the PBS. [ + ]
International Solar Biofuels Consortium
The International Solar Biofuels Consortium was established in 2006 to promote scientific and industrial collaboration to promote biofuels and renewable energy. [ + ]
Dow AgroSciences and PICSE help students into science careers
Dow AgroSciences has joined forces with PICSE (Primary Industry Centre for Science Education) to help attract Australia’s future scientists to careers in agribusiness and research.
[ + ]UWA Vice-Chancellor to retire
The University of Western Australia’s Vice-Chancellor Professor Alan Robson has announced his retirement from the position at the end of 2011.
[ + ]Feature: Peter Doherty and the quest for a flu vaccine
Professor Peter Doherty has written his last grant application. But the 69-year-old Nobel Laureate hasn’t retired quite yet. [ + ]
Needle-free vaccine technology a step closer to clinical trials
Researchers at The University of Queensland believe they are a step closer to ridding the world of vaccinations with needles and syringes.
[ + ]